1. Home
  2. RCEL vs CCIR Comparison

RCEL vs CCIR Comparison

Compare RCEL & CCIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCEL
  • CCIR
  • Stock Information
  • Founded
  • RCEL N/A
  • CCIR 2021
  • Country
  • RCEL United States
  • CCIR United States
  • Employees
  • RCEL N/A
  • CCIR N/A
  • Industry
  • RCEL Medical/Dental Instruments
  • CCIR
  • Sector
  • RCEL Health Care
  • CCIR
  • Exchange
  • RCEL Nasdaq
  • CCIR NYSE
  • Market Cap
  • RCEL 308.6M
  • CCIR 326.6M
  • IPO Year
  • RCEL N/A
  • CCIR 2024
  • Fundamental
  • Price
  • RCEL $9.75
  • CCIR $11.10
  • Analyst Decision
  • RCEL Buy
  • CCIR
  • Analyst Count
  • RCEL 5
  • CCIR 0
  • Target Price
  • RCEL $17.25
  • CCIR N/A
  • AVG Volume (30 Days)
  • RCEL 191.4K
  • CCIR 37.9K
  • Earning Date
  • RCEL 02-13-2025
  • CCIR 01-01-0001
  • Dividend Yield
  • RCEL N/A
  • CCIR N/A
  • EPS Growth
  • RCEL N/A
  • CCIR N/A
  • EPS
  • RCEL N/A
  • CCIR N/A
  • Revenue
  • RCEL $64,251,000.00
  • CCIR N/A
  • Revenue This Year
  • RCEL $62.11
  • CCIR N/A
  • Revenue Next Year
  • RCEL $31.19
  • CCIR N/A
  • P/E Ratio
  • RCEL N/A
  • CCIR N/A
  • Revenue Growth
  • RCEL 28.14
  • CCIR N/A
  • 52 Week Low
  • RCEL $7.51
  • CCIR $9.98
  • 52 Week High
  • RCEL $18.93
  • CCIR $12.20
  • Technical
  • Relative Strength Index (RSI)
  • RCEL 50.10
  • CCIR N/A
  • Support Level
  • RCEL $8.37
  • CCIR N/A
  • Resistance Level
  • RCEL $11.25
  • CCIR N/A
  • Average True Range (ATR)
  • RCEL 0.55
  • CCIR 0.00
  • MACD
  • RCEL 0.22
  • CCIR 0.00
  • Stochastic Oscillator
  • RCEL 47.92
  • CCIR 0.00

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

About CCIR COHEN CIRCLE ACQUISITION CORP I

Cohen Circle Acquisition Corp I is a blank check company.

Share on Social Networks: